Evaluation and clinical management of drug-drug interactions in hypertensive patients associated co-morbidities: A study in general medicine and ICU ward

---

Original Article

Author Details : Rohit Kumar, Avinash Teli*, Pooja Rathore, Vishal Kumar, Sharookh Ali

Volume : 11, Issue : 1, Year : 2023

Article Page : 57-65

https://doi.org/10.18231/j.jpbs.2023.010

Suggest article by email

Get Permission

---

Abstract

This comparative study aims to evaluate and compare the clinical management of drug-drug interactions (DDIs) in hypertensive patients with associated co-morbidities, specifically focusing on the practices in general medicine and ICU ward settings. Hypertensive patients commonly experience co-morbidities that require multiple medications, increasing the risk of DDIs and subsequent adverse events. Understanding the current evaluation and management strategies for DDIs in these patient populations is essential for optimizing patient outcomes. This research investigates the approaches employed in general medicine and ICU wards, including DDI identification, assessment, and intervention methods. By comparing these practices, the study aims to identify potential variations, challenges, and areas for improvement in DDI management across these clinical settings. The findings of this study will contribute to the development of evidence-based guidelines and recommendations for enhancing the clinical management of DDIs in hypertensive patients with co-morbidities, ultimately improving patient safety and therapeutic outcomes.

Keywords: Drug- drug interactions, Hypertension, Co-morbidities, Multidisciplinary approach, General medicine, ICU, Patient Safety, Therapeutic outcomes

How to cite : Kumar R, Teli A, Rathore P, Kumar V, Ali S, Evaluation and clinical management of drug-drug interactions in hypertensive patients associated co-morbidities: A study in general medicine and ICU ward. J Pharm Biol Sci 2023;11(1):57-65

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.